EUVIMEDEUVIMED entdecken
Pragmatische StudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Preventing Postpartum Venous Thromboembolism With Low‐Molecular‐Weight Heparin: The PP‐HEP Pilot Randomised Controlled Trial

Marc Blondon iD, Marine Claver, Emilienne Celetta, Marc Righini, Begoña Martinez de Tejada

BJOG: An International Journal of Obstetrics & Gynaecology · 2025-01 · 132 (1) · 35-43

DOI: 10.1111/1471-0528.17943 ↗

Kurz gefasst

Pragmatische Studie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, online erschienen am 05.09.2024. Verfasst von Marc Blondon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Angiology and Hemostasis, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland. Hauptthemen laut MEDLINE: Anticoagulants, Enoxaparin, Venous Thromboembolism. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hôpitaux Universitaires de Genève.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective Uncertainty surrounds the risk–benefit of low‐molecular‐weight heparin to prevent postpartum venous thromboembolism (VTE). Data from randomised clinical trials (RCT) are critically needed, but recent feasibility studies in North America yielded low participation rates, with

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsEnoxaparinVenous ThromboembolismAdultFemaleHumansPregnancyFeasibility StudiesHeparin, Low-Molecular-WeightPilot ProjectsPostpartum PeriodPuerperal DisordersRisk FactorsSwitzerlandTreatment Outcome

Stichwörter der Autor:innen

low‐molecular‐weight heparinpostpartumpregnancyvenous thrombosis

Substanzen

AnticoagulantsEnoxaparinHeparin, Low-Molecular-Weight

Autor:innen und Institutionen

  • Division of Angiology and Hemostasis, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.
  • Division of Obstetrics, Department of Paediatrics, Gynecology and Obstetrics, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.

ORCID-Profile: Marc Blondon

Förderung

  • Hôpitaux Universitaires de Genève

Zitieren

APA

Blondon, M., Claver, M., Celetta, E., Righini, M., & de Tejada, B. M. (2025). Preventing Postpartum Venous Thromboembolism With Low‐Molecular‐Weight Heparin: The PP‐HEP Pilot Randomised Controlled Trial. BJOG: An International Journal of Obstetrics & Gynaecology, 132(1), 35-43. https://doi.org/10.1111/1471-0528.17943

Vancouver

Blondon M, Claver M, Celetta E, Righini M, de Tejada BM. Preventing Postpartum Venous Thromboembolism With Low‐Molecular‐Weight Heparin: The PP‐HEP Pilot Randomised Controlled Trial. BJOG: An International Journal of Obstetrics & Gynaecology. 2025;132(1):35-43. doi:10.1111/1471-0528.17943

BibTeX
@article{Blondon2025,
  author = {Blondon, Marc and Claver, Marine and Celetta, Emilienne and Righini, Marc and de Tejada, Begoña Martinez},
  title = {Preventing Postpartum Venous Thromboembolism With Low‐Molecular‐Weight Heparin: The PP‐HEP Pilot Randomised Controlled Trial},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2025},
  volume = {132},
  number = {1},
  pages = {35--43},
  doi = {10.1111/1471-0528.17943}
}
Kostenlos starten →